Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026 PA Media

Axtria is set to develop the largest AI engineering group specialized for the pharmaceutical industry, reaching 1,000 members by December 2026. This move responds to rising demands in life sciences.

/PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced plans to expand its Forward...

BERKELEY HEIGHTS, N.J., Aug. 13, 2026 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the...

Join us 4th-5th June 2025 for Axtria Ignite, an event focused on AI-powered pharma leadership and transformation. Don't miss out on this opportunity to learn from industry experts and network with pee...

Axtria Inc., an AI-first data analytics innovator and global provider of cloud software to the life sciences industry, today announced its next generation of Axtria InsightsMAx, powered by agentic AI.

In a shocking revelation this January 2026, Axtria, a major player in cloud-based sales and AI solutions, suffered a significant cybersecurity breach. Proprietary source code for its SalesIQ platform, AI/copilot assets, and backend systems has reportedly been leaked on DarkForums, a notorious dark web hub for cybercriminals. Among the exposed repositories are salesiq_icnextgen, salesiq_reporting, and sales, raising serious concerns about intellectual property theft and potential downstream impacts on clients and partners relying on Axtria’s cloud solutions.

Axtria Inc., an AI-first data analytics innovator and global provider of cloud software to the life sciences industry, today announced its next generation of Axtria InsightsMAx, powered by agentic AI.

 

Over 450 executives from leading life sciences firms gathered at Axtria Ignite 2026, addressing crucial AI challenges. Insightful discussions focused on foundational improvements for successful AI implementation.

Axtria and LangChain partner to enhance AI agents in the pharmaceutical industry, ensuring efficient deployment and regulatory compliance.

Axtria Inc. has acquired Conexus Solutions, merging their AI capabilities and CRM expertise to reshape life sciences commercialization. This strategic move promises to deliver integrated solutions that enhance patient outcomes and streamline operations.

Axtria Inc. has been recognized as Frost & Sullivan's 2025 Global Company of the Year for its innovative AI-driven solutions in the pharmaceutical sector.

Axtria Inc. has been honored with Great Place to Work® certification in both India and the U.S. for its commitment to employee satisfaction and a positive workplace culture.

Axtria Inc. has launched the sixth edition of its annual U.S. Incentive Compensation Benchmarking Study, offering valuable data-driven insights for the life sciences industry.

Axtria Inc. announces Ignite Global 2026, focusing on the future of AI-powered ownership. Senior leaders will discuss AI's role in decision-making.

Axtria's new AI-Powered Launch Excellence program is designed to accelerate success for emerging pharma companies by integrating data analytics, consulting, and strategy.